Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects

Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects

Yu-Jung Cha,1,* Kyoung Soo Lim,2,* Min-Kyu Park,1 Stephen Schneider,3 Brian Bray,3 Myung-Chol Kang,3 Jae-Yong Chung,1 Seo Hyun Yoon,1 Joo-Youn Cho,1 Kyung-Sang Yu11Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea; 2...

Full description

Bibliographic Details
Main Authors: Cha YJ, Lim KS, Park MK, Schneider S, Bray B, Kang MC, Chung JY, Yoon SH, Cho JY, Yu KS
Format: Article
Language:English
Published: Dove Medical Press 2014-09-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/pharmacokinetics-and-tolerability-of-the-new-second-generation-nonnucl-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/pharmacokinetics-and-tolerability-of-the-new-second-generation-nonnucl-peer-reviewed-article-DDDT

Similar Items